Risk factors for venous thromboembolism after lung transplantation

Chest

Volumn 132, Issue 2, 2007, Pages 547-553

  Yegen, Hilary A ^a   Lederer, David J ^a   Barr, R Graham ^a   Wilt, Jessie S ^a   Fang, Yixin ^b   Bagiella, Emilia ^c   D'Ovidio, Frank ^a   Okun, Jeffrey M ^a   Sonett, Joshua R ^a   Arcasoy, Selim M ^a   Kawut, Steven M ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

Lung transplantation; Pulmonary embolism; Venous thrombosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; ESTROGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; AGING; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; INCIDENCE; LUNG EMBOLISM; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 34548028253     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0035     Document Type: Article

References (43)

1. Kotloff RM, Ahya VN. Medical complications of lung transplantation. Eur Respir J 2004; 23:334-342
2. Kroshus TJ, Kshettry VR, Hertz MI, et al. Deep venous thrombosis and pulmonary embolism after lung transplantation. J Thorac Cardiovasc Surg 1995; 110:540-544
3. Nathan SD, Barnett SD, Urban BA, et al. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients. Chest 2003; 123:1758-1763
4. Burns KE, Iacono AT. Pulmonary embolism on postmortem examination: an under-recognized complication in lung-transplant recipients? Transplantation 2004; 77:692-698
5. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160:809-815
6. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-1231
7. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107:19-16
8. Samama MM, Dahl OE, Quinlan DJ, et al. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool. Haematologica 2003; 88:1410-1421
9. Joffe HV, Kucher N, Tapson VF, et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110:160.5-1611
10. Izbicki G, Bairey O, Shitrit D, et al. Increased thromboembolic events after lung transplantation. Chest 2006; 129:412-416
11. Kazory A, Ducloux D, Coaquette A, et al. Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation 2004; 77:597-599
12. Brunkwall J, Bergqvist D, Bergentz SE, et al. Postoperative deep venous thrombosis after renal transplantation: effects of cyclosporine. Transplantation 1987; 43:647-649
13. Langer RM, Kahan BD. Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients. Transplantation 2003; 76:318-323
14. Yegen HA, Lederer DJ, Wilt JS, et al. Risk factors for venous thromboembolism in lung transplant recipients [abstract]. Proc Am Thorac Soc 2005; 3:A536
15. Yip NH, Lederer DJ, Kawut SM, et al. Immunoglobulin G levels before and after lung transplantation. Am J Respir Crit Care Med 2006; 173:917-921
16. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112:416-422
17. Center for Drug Evaluation and Research, Food and Drug Administration, US Department of Health and Human Services. Guidance for industry: evaluating clinical studies of antimicrobials in the division of anti-infective drug products (draft). Available at: http://www.fda.gov/cder/guidance/ draft9al.pdf. Accessed July 14, 2006
18. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction: part II. Definition: a consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24:1454-1459
19. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21:297-310
20. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15:1-15
21. Borgan O, Goldstein L, Langholz B. Methods for the analysis of sampled cohort data in the Cox proportional hazards model. Ann Stat 1995; 23:1749-1778
22. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2000; 132:689-696
23. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160:3415-3420
24. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162:1182-1189
25. Petrauskiene V, Falk M, Waernbaum I, et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48:1017-1021
26. Humar A, Johnson EM, Gillingham KJ, et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation 1998; 65:229-234
27. Bergqvist D, Bergentz SE, Bornmyr S, et al. Deep vein thrombosis after renal transplantation: a prospective analysis of frequency and risk factors. Eur Surg Res 1985; 17:69-74
28. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888-1904
29. Christie JD, Robinson N, Ware LB, et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175:69-74
30. Grignani G, Maiolo A. Cytokines and hemostasis. Haematologica 2000; 85:967-972
31. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131:417-430
32. Becker DM, Philbrick JT, Walker FBT. Axillary and subclavian venous thrombosis: prognosis and treatment. Arch Intern Med 1991; 151:1934-1943
33. Bernardi E, Piccioli A, Marchiori A, et al. Upper extremity deep vein thrombosis: risk factors, diagnosis, and management. Semin Vasc Med 2001; 1:105-110
34. Horattas MC, Wright DJ, Fenton AH, et al. Changing concepts of deep venous thrombosis of the upper extremity: report of a series and review of the literature. Surgery 1988; 104:561-567
35. Monreal M, Raventos A, Lerma R, et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines: a prospective study. Thromb Haemost 1994; 72:548-550
36. Agnelli G, Verso M. Therapy insight: venous-catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 2006; 3:214-222
37. Hull RD, Brant RF, Pineo GF, et al. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999; 159:137-141
38. Strebel N, Prins M, Agnelli G, et al. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162:1451-1456
39. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82:496-501
40. Ramos R, Salem BI, De Pawlikowski MP, et al. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996; 109:82-85
41. Lausen I, Jensen R, Jorgensen LN, et al. Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis. Eur J Surg 1998; 164:657-663
42. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358:9-15
43. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:338S-400S